-
Document de presse | 2025.02.26
Argobio and the Institut Pasteur launch Enodia Therapeutics: A biotech company with a new approach for Targeted protein Degradation
Turning groundbreaking research from the Institut Pasteur with the support of Argobio’s start-up studio, into novel treatments for cancer, inflammatory diseases and viral infections. The platform leverages state-of-the-art generative artificial intelligence (AI) to design selective inhibitors of the Sec61/translocon molecular complex for blocking and degrading disease-causing proteins. Enodia...
-
Article | 2016.12.20
Amgen Scholars Program
The Amgen Scholars Program at Institut Pasteur will provide ten undergraduate students from European universities the opportunity to work on supervised research projects during an eight-week summer internship in Institut Pasteur.
-
Document de presse | 2025.03.06
Stand Up for Science: the Institut Pasteur is committed to defending science and supporting the solidarity movement towards the American scientific community
Recent events across the Atlantic, marked by attacks on scientific facts and against researchers, underline the urgent need for collective mobilization across the world. Echoing the Stand Up for Science Day initiated in the United States, scientists and academics in France are calling for mobilization actions in every city.The Institut Pasteur reaffirms its commitment to free, open and...
-
News | 2025.03.05
When bacterial DNA invades cells, does it have the code to adapt to its new environment?
A team from the Institut Pasteur used a combination of molecular biology, genomics and artificial chromosomes, aided by artificial intelligence (AI), to explore how a DNA molecule behaves when it enters the nucleus of a eukaryotic cell. Their research, published recently in the prestigious journal Science, reveals that the DNA's fate differs considerably depending on its sequence composition.
-
News | 2025.03.05
How the Immune System Regulates Breast Milk Production
The maternal immune system regulates lactation by differentiating the mammary glands during pregnancy. A specific population of lymphocytes promotes milk production and ejection, thereby improving the health of newborns. This discovery highlights the importance of maternal immune status and opens new avenues for addressing lactation challenges. The study was conducted by a team from the NIAID (...
-
Vidéo | 2025.03.10
What is whooping cough?
Whooping cough is a respiratory infection that can be very serious for infants and frail people.It causes a persistent cough, difficulty in breathing and can last for several weeks.The good news is that prevention is possible!Vaccination remains the most effective means of protecting babies and adults.Antibiotics can limit contagion if administered promptly.Wearing a mask helps reduce...
-
Fiche maladie | 2015.10.06
Viral hepatitis
Hepatitis is an inflammation of the liver caused by toxic substances or – in the majority of cases – by viruses. To date, five viruses have been identified that target the liver and cause inflammatory infection. These viruses are referred to by the letters A, B, C, D and E, and vary according to their transmission mode (fecal-oral for A and E, parenteral for B and C) and their aggressive profile.
-
Page avancée | 2025.03.11
Social responsibility at the Institut Pasteur
We are aware of our social responsibilities and pay close attention to the social, environmental and economic impact of all our activities. The Institut Pasteur supports the United Nations Global Compact and its 10 principles on human rights, labor standards, environmental protection and anti-corruption.We are committed to sustainable development and especially to reducing the environmental...
-
News | 2025.03.12
Avatar Medical, a spin-off from the Institut Pasteur, receives CE marking for its innovative solution «AVATAR MEDICAL Vision »
Avatar Medical Vision enables real-time conversion of patients' 2D medical images (such as MRIs and CT scans) into 3D, thus improving visualization and understanding of the patient's state of health. This CE certification represents a decisive step forward in democratizing access to medical imaging for surgeons and patients alike. AVATAR MEDICAL is a fine example of what Pasteurian research...
-
Document de presse | 2025.02.28
Bpifrance and the Institut Pasteur strengthen cooperation to support launch of startups based on research
On February 27, 2025, Yasmine Belkaid, President of the Institut Pasteur, and Nicolas Dufourcq, CEO of Bpifrance, signed a cooperation agreement aimed at using their resources and skills to improve the transfer to industry of research results. This strategic partnership is designed to encourage the emergence of startups and innovative projects based on the Institut Pasteur’s research. It follows...
